Legumain expression, activity and secretion are increased during monocyte-to-macrophage differentiation and inhibited by atorvastatin

Biological Chemistry

Volumn 396, Issue 1, 2015, Pages 71-80

  Solberg, Rigmor ^a   Smith, Robert ^a   Almlöf, Maria ^a   Tewolde, Eyassu ^a   Nilsen, Hilde ^a   Johansen, Harald Thidemann ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

asparaginyl endopeptidase (AEP); atorvastatin; cathepsin B; legumain; macrophage; monocyte

Indexed keywords

ATORVASTATIN; COLONY STIMULATING FACTOR 1; CYSTEINE PROTEINASE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LEGUMAIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CELL LYSATE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; MONOCYTE TO MACROPHAGE DIFFERENTIATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; CYTOLOGY; MACROPHAGE; METABOLISM; MONOCYTE;

ANTICHOLESTEREMIC AGENTS; CELL DIFFERENTIATION; CYSTEINE ENDOPEPTIDASES; HEPTANOIC ACIDS; HUMANS; MACROPHAGES; MONOCYTES; PYRROLES;

EID: 84913558372     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0172     Document Type: Article

References (47)

1. Alvarez-Fernandez, M., Barrett, A.J., Gerhartz, B., Dando, P.M., Ni, J.A., and Abrahamson, M. (1999). Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274, 19195-19203
2. Aewerx, J. (1991). The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31
3. Barrett, A.J. and Kirschke, H. (1981). Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80, 535-561
4. Berven, L., Johansen, H.T., Solberg, R., Kolset, S.O., and Samuelsen, A.B.C. (2013a). Autoactivation of prolegumain is accelerated by glycosaminoglycans. Biochimie 95, 772-781
5. Berven, L., Solberg, R., Truong, H.H.T., Arlov, ø., Lillelund Aachmann, F., Skjåk-Bræk, G., Egge-Jacobsen, W.M., Thidemann Johansen, H., and Samuelsen, A.B.C. (2013b). Alginates induce legumain activity in RAW 264.7 cells and accelerate autoactivation of prolegumain. Bioact. Carbohydr. Dietary Fibre 2, 30-44
6. Bradford, M.M. (1976). Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of proteindye binding. Anal. Biochem. 72, 248-254
7. Chan, C.B., Abe, M., Hashimoto, N., Hao, C., Williams, I.R., Liu, X., Nakao, S., Yamamoto, A., Li, S.Y., Asano, M., et al. (2009). Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome. Proc. Natl. Acad. Sci. USA 106, 468-473
8. Chen, J.M., Dando, P.M., Rawlings, N.D., Brown, M.A., Young, N.E., Stevens, R.A., Hewitt, E., Watts, C., and Barrett, A.J. (1997). Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272, 8090-8098
9. Chen, J.M., Rawlings, N.D., Stevens, R.A.E., and Barrett, A.J. (1998a). Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett. 441, 361-365
10. Chen, J.M., Dando, P.M., Stevens, R.A.E., Fortunato, M., and Barrett, A.J. (1998b). Cloning and expression of mouse legumain, a lysosomal endopeptidase. Biochem. J. 335, 111-117
11. Chen, J.M., Fortunato, M., Stevens, R.A.E., and Barrett, A.J. (2001). Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase. Biol. Chem. 382, 777-783
12. Choi, S.J., Reddy, S.V., Devlin, R.D., Menaa, C., Chung, H.Y., Boyce, B.F., and Roodman, G.D. (1999). Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J. Biol. Chem. 274, 27747-27753
13. Clerin, V., Shih, H.H., Deng, N., Hebert, G., Resmini, C., Shields, K.M., Feldman, J.L., Winkler, A., Albert, L., Maganti, V., et al. (2008). Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. Atherosclerosis 201, 53-66
14. Dall, E. and Brandstetter, H. (2013). Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation. Proc. Natl. Acad. Sci. USA 110, 10940-10945
15. Edgington, L.E., Verdoes, M., Ortega, A., Withana, N.P., Lee, J., Syed, S., Bachmann, M.H., Blum, G., and Bogyo, M. (2013). Functional imaging of legumain in cancer using a new quenched activity-based probe. J. Am. Chem. Soc. 135, 174-182
16. Halfon, S., Patel, S., Vega, F., Zurawski, S., and Zurawski, G. (1998). Autocatalytic activation of human legumain at aspartic acid residues. FEBS Lett. 438, 114-118
17. Hashimoto, S., Suzuki, T., Dong, H.Y., Nagai, S., Yamazaki, N., and Matsushima, K. (1999). Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94, 845-852
18. Huh, H.Y., Pearce, S.F., Yesner, L.M., Schindler, J.L., and Silverstein, R.L. (1996). Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation. Blood 87, 2020-2028
19. Johansen, H.T., Knight, C.G., and Barrett, A.J. (1999). Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis. Anal. Biochem. 273, 278-283
20. Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C.N., Bang, L.E., Bundgaard, H., Nielsen, L.B., Helge, J.W., and Dela, F. (2013). Simvastatin effects on skeletal muscle relation to decreased mitochondrial function and glucose intolerance. J. Am. Coll. Cardiol. 61, 44-53
21. Li, D.N., Matthews, S.P., Antoniou, A.N., Mazzeo, D., and Watts, C. (2003). Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278, 38980-38990
22. Liao, J.K. and Laufs, U. (2005). Pleiotropic effects of statins. Ann. Rev. Pharmacol. Toxicol. 45, 89-118
23. Lin, Y., Wei, C., Liu, Y., Qiu, Y., Liu, C., and Guo, F. (2013). Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer Sci. 104, 1217-1225
24. Liu, C., Sun, C.Z., Huang, H.N., Janda, K., and Edgington, T. (2003). Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63, 2957-2964
25. Luo, Y., Zhou, H., Krueger, J., Kaplan, C., Lee, S.H., Dolman, C., Markowitz, D., Wu, W., Liu, C., Reisfeld, R.A., et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J. Clin. Invest. 116, 2132-2141
26. Manoury, B., Hewitt, E.W., Morrice, N., Dando, P.M., Barrett, A.J., and Watts, C. (1998). An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396, 695-699
27. Marin, L., Colombo, P., Bebawy, M., Young, P.M., and Traini, D. (2011). Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Exp. Opin. Drug Deliv. 8, 1205-1220
28. Mattock, K.L., Gough, P.J., Humphries, J., Burnand, K., Patel, L., Suckling, K.E., Cuello, F., Watts, C., Gautel, M., Avkiran, M., et al. (2010). Legumain and cathepsin-L expression in human unstable carotid plaque. Atherosclerosis 208, 83-89
29. Miller, G., Matthews, S.P., Reinheckel, T., Fleming, S., and Watts, C. (2011). Asparagine endopeptidase is required for normal kidney physiology and homeostasis. FASEB J. 25, 1606-1617
30. Morita, Y., Araki, H., Sugimoto, T., Takeuchi, K., Yamane, T., Maeda, T., Yamamoto, Y., Nishi, K., Asano, M., Shirahama-Noda, K., et al. (2007). Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells. FEBS Lett. 581, 1417-1424
31. Papaspyridonos, M., Smith, A., Burnand, K.G., Taylor, P., Padayachee, S., Suckling, K.E., James, C.H., Greaves, D.R., and Patel, L. (2006). Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscl., Thromb. Vascul. Biol. 26, 1837-1844
32. Peres, C., Yart, A., Perret, B., Salles, J.P., and Raynal, P. (2003). Modulation of phosphoinositide 3-kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling. FEBS Lett. 534, 164-168
33. Pike, L.J. and Miller, J.M. (1998). Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormonestimulated phosphatidylinositol turnover. J. Biol. Chem. 273, 22298-22304
34. Qin, Z. (2012). The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221, 2-11
35. Schwende, H., Fitzke, E., Ambs, P., and Dieter, P. (1996). Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukocyte Biol. 59, 555-561
36. Sepulveda, F.E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon-Duménil, A.M., Amigorena, S., Cabanie, L., and Manoury, B. (2009). Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737-748
37. Shirahama-Noda, K., Yamamoto, A., Sugihara, K., Hashimoto, N., Asano, M., Nishimura, M., and Hara-Nishimura, I. (2003). Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice. J. Biol. Chem. 278, 33194-33199
38. Skottheim, I.B., Gedde-Dahl, A., Hejazifar, S., Hoel, K., and Åsberg, A. (2008). Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. Eur. J. Pharmaceutical. Sci. 33, 317-325
39. Slade, P.G., Hajivandi, M., Bartel, C.M., and Gorfien, S.F. (2012). Identifying the CHO secretome using mucin-type O-linked glycosylation and click-chemistry. J. Proteome Res. 11, 6175-6186
40. Smith, R., Johansen, H.T., Nilsen, H., Haugen, M.H., Pettersen, S.J., Mælandsmo, G.M., Abrahamson, M., and Solberg, R. (2012). Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M. Biochimie 94, 2590-2599
41. Smith, R., Solberg, R., Jacobsen, L.L., Voreland, A.L., Rustan, A.C., Thoresen, G.H., and Johansen, H.T. (2014). Simvastatin inhibits glucose uptake and legumain activity in human myotubes. PLoS One 9, e85721
42. Subtil, A., Gaidarov, I., Kobylarz, K., Lampson, M.A., Keen, J.H., and McGraw, T.E. (1999). Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc. Natl. Acad. Sci. USA 96, 6775-6780
43. van Der Meij, E., Koning, G.G., Vriens, P.W., Peeters, M.F., Meijer, C.A., Kortekaas, K.E., Dalman, R.L., van Bockel, J.H., Hanemaaijer, R., Kooistra, T., et al. (2013). A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation. PLoS One 8(1):e53882
44. Wang, Z.H., Liu, X.L., Zhong, M., Zhang, L.P., Shang, Y.Y., Hu, X.Y., Li, L., Zhang, Y., Deng, J.T., and Zhang, W. (2010). Pleiotropic effects of atorvastatin on monocytes in atherosclerotic patients. J. Clin. Pharmacol. 50, 311-319
45. Werle, B., Ebert, W., Klein, W., and Spiess, E. (1995). Assessment of cathepsin-L activity by use of the inhibitor Ca-074 compared to cathepsin-B activity in human lung tumor-tissue. Bio. Chem. Hoppe-Seyler 376, 157-164
46. Zeeuwen, P. (2004). Epidermal differentiation: the role of proteases and their inhibitors. Eur. J. Cell Biol. 83, 761-773
47. Zhao, L., Hua, T., Crowley, C., Ru, H., Ni, X., Shaw, N., Jiao, L., Ding, W., Qu, L., Hung, L.W., et al. (2014). Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage. Cell Res. 24, 344-358